Endomal-AT Injection contains Artesunate, an artemisinin derivative used for the treatment of severe malaria and other malaria cases where injectable therapy is clinically indicated.
Endomal-AT Injection contains Artesunate, an artemisinin derivative used for the treatment of severe malaria and other malaria cases where injectable therapy is clinically indicated.
Artesunate acts rapidly against malaria parasites by interfering with essential parasite processes, helping reduce the parasite burden.
Endomal-AT Injection should be administered only by a qualified healthcare professional through the appropriate parenteral route. The dose and dosing schedule are determined according to the patient's body weight, age, severity of malaria, and clinical condition. Do not self-administer.
Whether you're a distributor, wholesaler, healthcare professional, or business partner, we're ready to grow together.